FDA Inspection
Takeda Manufacturing Austria AGTakeda Manufacturing Austria AG – FDA Inspection, Feb 5, 2016
Record Details
This FDA Inspection record concerns Takeda Manufacturing Austria AG, with an inspection on February 5, 2016, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- February 5, 2016
- Product Type
- Biologics
View Company Profile
ID · 714d36e5-c95f-482d-a8df-c68809cded57
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 958990
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Takeda Manufacturing Austria AG
8| Date | Classification | Office | Project area |
|---|---|---|---|
| September 15, 2026 | Not classified | Office of Inspections and Investigations | Blood and Blood Products |
| July 17, 2026 | Not classified | Office of Inspections and Investigations | |
| June 24, 2022 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 2, 2018 | Not classified | Office of Inspections and Investigations | |
| January 31, 2012 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Takeda Manufacturing Austria AG
- FDA Inspection 1335724 - 2026-09-15
- FDA Inspection 1331016 - 2026-07-17
- FDA Inspection 1175171 - 2022-06-24
- FDA Inspection 1043241 - 2018-02-02
- FDA Inspection 772061 - 2012-01-31
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.